BRIEF-Teva 2014 revenue outlook

July 31 Thu Jul 31, 2014 8:38am EDT

July 31 (Reuters) - Teva Pharmaceutical Industries Ltd said:

* Sees 2014 revenue $19.5-$20.5 billion with Copaxone competition versus previous estimate $19.3-$20.3 billion Further company coverage: (Reporting by Tova Cohen)

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article